Health Canada Approves Multaq(TM) (dronedarone) for Patients with Atrial Fibrillation
First new treatment option in over 20 years for condition affecting 250,000 Canadians
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.